Clinical Trial News Archive - November 2017

November 1, 2017

AbbVie Announces Positive Phase 3 Extension Study Data for Investigational Oral Treatment Elagolix for Management of Endometriosis with Associated Pain

November 2, 2017

Alnylam and Sanofi Present Positive Complete Results from APOLLO Phase 3 Study of Investigational Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy

November 3, 2017

Alnylam Reports Positive Preliminary Results from Ongoing Phase 1/2 Study of Lumasiran (ALN-GO1) in Patients with Primary Hyperoxaluria Type 1 (PH1)
Phase 3 Studies of the Tezacaftor/Ivacaftor Combination Treatment in People with Cystic Fibrosis Ages 12 and Older Published in the New England Journal of Medicine

November 6, 2017

November 7, 2017

Alnylam Initiates ENVISION Phase 3 Clinical Study with Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias (AHPs)

November 8, 2017

Seattle Genetics and Astellas Initiate Phase 1b Trial of Enfortumab Vedotin in Combination with Immune Checkpoint Inhibitor Therapies in Locally Advanced or Metastatic Urothelial Cancer

November 9, 2017

Sage Therapeutics Announces Brexanolone Achieves Primary Endpoints in Both Phase 3 Clinical Trials in Postpartum Depression

November 10, 2017

Three-year Follow-up Phase 3 Data Provide Additional Information on Efficacy, Durability and Safety of Investigational Luxturna (voretigene neparvovec) in Patients with Biallelic RPE65-mediated Inherited Retinal Disease

November 20, 2017

Intra-Cellular Therapies Receives FDA Fast Track Designation for Lumateperone for the Treatment of Schizophrenia

November 27, 2017

Biohaven Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of Oral CGRP-Receptor Antagonist Rimegepant

November 29, 2017

Clinical trial results archive

2024: January, February, March, April, May
2023: January, February, March, April, May, June, July, August, September, October, November, December
2022: January, February, March, April, May, June, July, August, September, October, November, December
2021: January, February, March, April, May, June, July, August, September, October, November, December
2020: January, February, March, April, May, June, July, August, September, October, November, December
2019: January, February, March, April, May, June, July, August, September, October, November, December
2018: January, February, March, April, May, June, July, August, September, October, November, December
2017: May, June, July, August, September, October, November, December
2016: October

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Recently Approved

Imdelltra
Imdelltra (tarlatamab-dlle) is a first-in-class, bispecific delta-like ligand 3...
Myhibbin
Myhibbin (mycophenolate mofetil) is an antimetabolite immunosuppressant used...
Beqvez
Beqvez (fidanacogene elaparvovec-dzkt) is an adeno-associated virus...

More drug approvals